Videos by AllCells in Alameda. Quality Cells for Quality Science
Did you know we are the only CGT starting materials provider offering both volume-based and cell-count-based RUO Leukopaks? This dual capability offers CGT developers the ability to choose the best option for their specific project needs, timelines, and budgets—without compromising on quality.
AllCells® Volume-Based Leukopaks: The standard format for transitioning from RUO to GMP with an average of 15 billion total nucleated cells (TNCs), ideal for maximizing project flexibility.
AllCells® Cell-Count-Based Leukopaks: A more budget-friendly option of 10 billion TNCs with enhanced lot-to-lot consistency.
Contact us to learn more about these options: https://allcells.com/research-grade-tissue-products/leukopak/?#form
Did you know we are the only CGT starting materials provider offering both volume-based and cell-count-based RUO Leukopaks? This dual capability offers CGT developers the ability to choose the best option for their specific project needs, timelines, and budgets—without compromising on quality. AllCells® Volume-Based Leukopaks: The standard format for transitioning from RUO to GMP with an average of 15 billion total nucleated cells (TNCs), ideal for maximizing project flexibility. AllCells® Cell-Count-Based Leukopaks: A more budget-friendly option of 10 billion TNCs with enhanced lot-to-lot consistency. Contact us to learn more about these options: https://allcells.com/research-grade-tissue-products/leukopak/?#form
AllCells® Matched Immune Cell Subsets are cryopreserved and assay-ready, empowering scientists to overcome cell source variability and achieve high-quality, reliable results in CGT, immunotherapy, infectious disease, and vaccine development. Request a quote today and get 20% off with promo code “Match20”. No minimum purchase is required. Take advantage of this special deal today: https://allcells.com/isolated-cell-products/#matched-sets
Accelerate Complex CGT Programs and Optimize Your Supply Chain
Discovery Life Sciences specializes in leukapheresis and custom prospective collections of high-quality CGT starting materials. Our AllCells RUO and GMP products, along with integrated analytical services, have supported complex CGT programs transition seamlessly from early discovery to process development and manufacturing, with an average 98% collection deliverability rate.
Connect with us today and let’s shape the future of CGT together!
#celltherapy #genetherapy #cellandgenetherapy
The recording for our webinar, “Precision Donor Management for Complex CGT Projects,” is now available! AllCells experts engaged in an insightful discussion on how our unique donor management approach achieves the industry-best collection deliverability across a range of real-world complex projects. Watch the on-demand video now: https://allcells.com/webinars/precision-donor-management-for-complex-cgt-projects/
Join our panel of AllCells experts for a LinkedIn Live event to learn how our donor management approach achieves an average 98% collection deliverability for complex cell and gene therapy (CGT) projects. Gain practical insights from real-world case studies demonstrating how our unique approach can enable success for your programs. The webinar will be streamed on Thursday, April 10 at 3pm Eastern Time (ET). Register today: https://www.linkedin.com/events/precisiondonormanagementforcomp7181293122671271938/theater/
AllCells’ new donor management case studies are now available! Featuring 5 real-world examples of how our disruptive approach provides a remarkable collection deliverability rate across a diverse range of complex CGT projects. Download here: https://go.allcells.com/dm-case-studies-brochure #cellandgenetherapy
For a limited time, get 20% off Cord Blood CD34+ Cells isolated from a single umbilical cord, ideal for applications that require the bypassing of HLA mismatch. Request a quote today using promo code 20OFFCB: https://allcells.com/research-grade-tissue-products/cord-blood/ AllCells’ umbilical cord blood is a rich source of primitive CD34+ HSPCs, which exhibit higher proliferative engraftment and multipotent potential compared to those isolated from adult bone marrow. Speak with us to take advantage of this offer! #CellTherapy #GeneTherapy #Immunotherapies #AllCells #DLS
Get your CGT projects off the ground quickly by getting mobilized leukopaks containing high CD34+ yield and low granulocyte content in just 3 weeks. Download AllCells’ new tech note to learn more: https://go.allcells.com/l/996581/2024-02-27/25xjt #CellTherapy #Immunotherapies #AllCells #DLS
Partner with AllCells to bulk-isolate and cryopreserve a high yield of CD34+ HSPCs from single-donor mobilized leukopaks. Create a reliable, quality-controlled cell bank with a guaranteed >90% CD34+ purity to ensure reliability and standardization for your CGT projects. Speak with us today: https://allcells.com/research-grade-tissue-products/mobilized-leukopak/ #celltherapymanufacturing #celltherapy #genetherapy #DLS #AllCells
Get mobilized with AllCells! We are a market leader in mobilized apheresis collection, delivering high yield of CD34+ HSPCs with the shortest lead time – receive your fresh Mobilized Leukopaks in just 3 weeks with standard donor attributes. Select from four off-the-shelf regimens or collaborate with our experts to design collections with custom attributes. Ready to mobilize? Connect with our specialists today to discover if you qualify for a limited-time special offer. https://allcells.com/research-grade-tissue-products/mobilized-leukopak/ #CellTherapies #GeneTherapies #Immunotherapies #AllCells #DLS
Ready to maximize your budget? Take advantage of the ongoing AllCells’ Year-End Special Event and stock up with 50% off Isolated PBMCs for your upcoming projects. These PBMCs are in high demand and supplies are limited. Discover how you can make the most of your budget with this incredible offer: https://pages.allcells.com/allcells-year-end-promos-2023 #YearEndSpecial #DiscountOffer #CellTherapy #GeneTherapy
Successful cell and gene therapy (CGT) development begins with high-quality starting materials. AllCells' GMP Mobilized Leukopaks with clinical-grade CD34+ cells are a market-leading option that have helped hundreds of CGT developers and manufacturers optimize their CGT workflows to achieve a faster time-to-market. - 99% deliverability rate from our recallable and reliable donor pool - 97% average cell viability and 1.25% CD34+ cell frequency - Mitigate donor deferral issues with the Parallel Donor Program Contact us today to learn more: https://allcells.com/gmp/mobilized-leukopak-gmp-compliant/?#form #CellTherapy #GeneTherapy #Immunotherapies #AllCells #DLS
Stock your freezers with our premium-quality Mobilized CD34+ Hematopoietic Stem and Progenitor Cells (HSPCs). Take advantage of our ongoing Year-End Special Event and get 50% off the list price on HSPCs. Elevate your cell and gene therapy projects at an incredible discount. Use promo code MLPCD34 from now until December 31, 2023, to make the most of your budget. Get a free quote: https://pages.allcells.com/allcells-year-end-promos-2023 #CellTherapy #GeneTherapy #Immunotherapies #AllCells #DLS
Learn how AllCells’ continued expansion is reducing the cost of Leukopaks. Our expanding apheresis network enables industry-leading capacity, serving the cell and gene therapy industry with a 99% delivery rate. - 10,000+ recallable HLA-typed donors - Strategically-located collection facilities with same-day and next-day delivery options - Seamless transition from research use to GMP material https://pages.allcells.com/largest-apheresis-capacity